Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Chagas disease in immunocompromised patients
EH Clark, LA Messenger, JD Whitman… - Clinical Microbiology …, 2024 - journals.asm.org
As Chagas disease remains prevalent in the Americas, it is important that healthcare
professionals and researchers are aware of the screening, diagnosis, monitoring, and …
professionals and researchers are aware of the screening, diagnosis, monitoring, and …
Pathology and pathogenesis of Chagas heart disease
KM Bonney, DJ Luthringer, SA Kim… - Annual Review of …, 2019 - annualreviews.org
Chagas heart disease is an inflammatory cardiomyopathy that develops in approximately
one-third of people infected with the protozoan parasite Trypanosoma cruzi. One way T …
one-third of people infected with the protozoan parasite Trypanosoma cruzi. One way T …
SBC guideline on the diagnosis and treatment of patients with cardiomyopathy of Chagas disease–2023
SciELO - Brasil - Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com
Cardiomiopatia da Doença de Chagas – 2023 Diretriz da SBC sobre Diagnóstico e …
Cardiomiopatia da Doença de Chagas – 2023 Diretriz da SBC sobre Diagnóstico e …
Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease
Chagas disease caused by Trypanosoma cruzi remains an important neglected tropical
disease and a cause of significant morbidity and mortality. No longer confined to endemic …
disease and a cause of significant morbidity and mortality. No longer confined to endemic …
Immunoregulatory networks in human C hagas disease
Chagas disease, caused by the infection with T rypanosoma cruzi, is endemic in all L atin A
merica. Due to the increase in population migration, C hagas disease has spread worldwide …
merica. Due to the increase in population migration, C hagas disease has spread worldwide …
New insights into Trypanosoma cruzi genetic diversity, and its influence on parasite biology and clinical outcomes
MMA Silvestrini, GD Alessio, BED Frias… - Frontiers in …, 2024 - frontiersin.org
Chagas disease, caused by Trypanosoma cruzi, remains a serious public health problem
worldwide. The parasite was subdivided into six distinct genetic groups, called “discrete …
worldwide. The parasite was subdivided into six distinct genetic groups, called “discrete …
IL-10/STAT3/SOCS3 axis is involved in the anti-inflammatory effect of benznidazole
Anti-parasitic treatment for Chagas disease mainly relies on benznidazole, which is virtually
the only drug available in the market. Besides its anti-parasitic effects, benznidazole has anti …
the only drug available in the market. Besides its anti-parasitic effects, benznidazole has anti …
PARP1-cGAS-NF-κB pathway of proinflammatory macrophage activation by extracellular vesicles released during Trypanosoma cruzi infection and Chagas disease
Trypanosoma cruzi (T. cruzi) is the etiological agent of Chagas cardiomyopathy. In the
present study, we investigated the role of extracellular vesicles (Ev) in sha** the …
present study, we investigated the role of extracellular vesicles (Ev) in sha** the …
Vesicles from different Trypanosoma cruzi strains trigger differential innate and chronic immune responses
PM Nogueira, K Ribeiro, ACO Silveira… - Journal of …, 2015 - Taylor & Francis
Trypomastigote forms of Trypanosoma cruzi, the causative agent of Chagas Disease, shed
extracellular vesicles (EVs) enriched with glycoproteins of the gp85/trans-sialidase (TS) …
extracellular vesicles (EVs) enriched with glycoproteins of the gp85/trans-sialidase (TS) …
Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas–2023
A DC (tripanossomíase americana) é entidade mórbida transmissível, potencialmente fatal,
causada pelo protozoário parasita T. cruzi e que integra o grupo de doenças tropicais …
causada pelo protozoário parasita T. cruzi e que integra o grupo de doenças tropicais …